News
Respiratory syncytial virus and the race for a vaccine
November 21 by Leila Hawkins
As cases of RSV surge vaccine manufacturers are racing to find a treatment
Big pharma CEOs announce net zero action plan
November 03 by Leila Hawkins
Seven major pharma companies join forces to tackle the sector’s greenhouse gas emissions
Uganda declares lockdown, Merck to donate vaccine to tackle Ebola
October 26 by Leila Hawkins
Uganda is trying to contain the latest outbreak of the Sudan variant of Ebola
Ukraine's clinical trials still recruiting despite ongoing war
October 12 by Leila Hawkins
Clinical research in Ukraine is showing signs of recovery more than seven months since war began
The impact of the energy crisis on pharma
October 03 by Leila Hawkins
The rising cost of energy is leading to “radical” cost-cutting and green alternatives
Trust in pharma has grown since the pandemic, survey finds
April 29 by Leila Hawkins
Pandemic boosts confidence in pharma according to the 2022 Edelman Trust Barometer
AstraZeneca shares positive results for its drug to lower cholesterol
April 13 by Leila Hawkins
Pharma IQ speaks to AstraZeneca about its promising new drug candidate to tackle one of the world’s leading causes of death
Solving the challenges of dry powder inhalation
April 06 by Leila Hawkins
Pharma IQ speaks to DFE Pharma about its new partnership to help pharma companies develop complex dry powder inhalation for respiratory conditions
Keeping tabs on pharma: Landmark new drug approvals and Sanofi’s diversity push
April 05 by Leila Hawkins
Pharma IQ’s latest round-up has the latest drug approvals for Gilead and AstraZeneca
Sanofi announces partnership to develop new class of oncology therapeutics
March 30 by Leila Hawkins
Pharma IQ speaks to IGM Biosciences and Sanofi about their new collaboration
Keeping tabs on pharma: First precision medicine for autism spectrum disorders
March 28 by Leila Hawkins
Pharma IQ’s latest news round-up looks at the first precision medicine for autism spectrum disorders, AstraZeneca’s preventative Covid-19 shot and India’s rising cost of medication
Keeping tabs on pharma: Clinical trials on pause in Russia
March 16 by Leila Hawkins
In Pharma IQ’s latest news round-up: Clinical trials pause in Russia but medical supplies will continue
